Health Land Corporation
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Health Land Corporation
No Result
View All Result
Home Health Care

Weight-loss drugs reduce kidney complication risks: Study

by
May 24, 2024
in Health Care
0
Weight-loss drugs reduce kidney complication risks: Study

The active ingredient in Ozempic and Wegovy may help reduce the risk of kidney failure in those with Type 2 diabetes and chronic kidney disease, according to a study published in the New England Journal of Medicine.

Researchers across 28 countries randomly assigned patients with Type 2 diabetes and chronic kidney disease to receive a weekly injection of 1 milligram of semaglutide, the active ingredient in Ozempic, or a placebo. Roughly 3,500 patients participated in the study, with half receiving semaglutide and the other half a placebo.

The study, which began in 2019, was funded by Novo Nordisk, which manufactures semaglutide.

In follow-ups among participants, the risk of a kidney disease events was found to be 24 percent lower in the semaglutide group than the placebo group.

“Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease,” researchers concluded.

Novo Nordisk announced in October it was halting its trial on kidney outcomes early due to already meeting “certain pre-specified criteria.”

According to the National Institute of Diabetes and Digestive and Kidney Diseases, diabetes is the leading cause of kidney disease, with 1 in 3 diabetics having the condition. About 12 percent of the U.S. population is estimated to have diabetes.

In the U.S., semaglutide is approved for treating Type 2 diabetes and obesity and for reducing the risk of major cardiovascular events. The latter is the most recent, with federal regulators granting the approval based on the results of a multinational study also funded by Novo Nordisk earlier this year.

Other GLP-1 agonists similar to Ozempic are similarly being tested to see if they may be able to treat conditions other than diabetes and obesity. Tirzepatide, sold under the name Mounjaro by Eli Lilly, is currently being studied for any potential benefits in treating chronic kidney disease in patients with obesity with or without Type 2 diabetes.

Previous studies have indicated GLP-1 agonists may be able to help with other conditions like addiction and reducing the risk of dementia.

Previous Post

Democrats see Supreme Court crisis in second Alito flag controversy

Next Post

Sparks fly over SNAP at contentious markup of House farm bill

Next Post
Sparks fly over SNAP at contentious markup of House farm bill

Sparks fly over SNAP at contentious markup of House farm bill

  • Trending
  • Comments
  • Latest
How to untangle ethics of psychedelics for therapeutic care

How to untangle ethics of psychedelics for therapeutic care

May 2, 2024
Novel therapy reduces depression in family caregivers

Novel therapy reduces depression in family caregivers

June 4, 2022
Planned Parenthood to spend $40m to boost Biden, Democrats ahead of November

Planned Parenthood to spend $40m to boost Biden, Democrats ahead of November

June 24, 2024
2 years in, 988 has answered 10 million calls, texts and chats

2 years in, 988 has answered 10 million calls, texts and chats

July 16, 2024
Judge orders many NIH grants restored, calling cancellation unlawful

Judge orders many NIH grants restored, calling cancellation unlawful

0
Chan School dean outlines ‘action agenda’ for global health

Chan School dean outlines ‘action agenda’ for global health

0
There are 5 easy steps to tame COVID-19, says Fauci

There are 5 easy steps to tame COVID-19, says Fauci

0
Infertility history linked with increased risk of heart failure

Infertility history linked with increased risk of heart failure

0
Judge orders many NIH grants restored, calling cancellation unlawful

Judge orders many NIH grants restored, calling cancellation unlawful

June 16, 2025
Abortion providers devastated by political killings, hit list  

Abortion providers devastated by political killings, hit list  

June 16, 2025
White House denies reporting by Guardian on VA benefits: ‘Totally FALSE story’

White House denies reporting by Guardian on VA benefits: ‘Totally FALSE story’

June 16, 2025
Senate version of Trump agenda bill cuts more from Medicaid: GOP aides

Senate version of Trump agenda bill cuts more from Medicaid: GOP aides

June 16, 2025

Enter Your Information Below To Receive Latest News And Articles

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time

    Recent News

    Judge orders many NIH grants restored, calling cancellation unlawful

    Judge orders many NIH grants restored, calling cancellation unlawful

    June 16, 2025
    Abortion providers devastated by political killings, hit list  

    Abortion providers devastated by political killings, hit list  

    June 16, 2025
    White House denies reporting by Guardian on VA benefits: ‘Totally FALSE story’

    White House denies reporting by Guardian on VA benefits: ‘Totally FALSE story’

    June 16, 2025
    Senate version of Trump agenda bill cuts more from Medicaid: GOP aides

    Senate version of Trump agenda bill cuts more from Medicaid: GOP aides

    June 16, 2025

    Recent News

    Judge orders many NIH grants restored, calling cancellation unlawful

    Judge orders many NIH grants restored, calling cancellation unlawful

    June 16, 2025
    Abortion providers devastated by political killings, hit list  

    Abortion providers devastated by political killings, hit list  

    June 16, 2025

    Popular News

    • Judge orders many NIH grants restored, calling cancellation unlawful
    • Abortion providers devastated by political killings, hit list  

    About Health Land Corporation

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2024 Healthlandcorporation.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2024 Healthlandcorporation.com. All Rights Reserved.